New	O
vectors	O
and	O
strategies	O
for	O
cardiovascular	B-Anatomical_system
gene	O
therapy	O
.	O

Cardiovascular	B-Anatomical_system
diseases	O
are	O
the	O
major	O
cause	O
of	O
morbidity	O
and	O
mortality	O
in	O
both	O
men	O
and	O
women	O
in	O
industrially	O
developed	O
countries	O
.	O

These	O
disorders	O
may	O
result	O
from	O
impaired	O
angiogenesis	O
,	O
particularly	O
in	O
response	O
to	O
hypoxia	O
.	O

Despite	O
many	O
limitations	O
,	O
gene	O
therapy	O
is	O
still	O
emerging	O
as	O
a	O
potential	O
alternative	O
for	O
patients	O
who	O
are	O
not	O
candidates	O
for	O
traditional	O
revascularization	O
procedures	O
,	O
like	O
angioplasty	O
or	O
vein	B-Multi-tissue_structure
grafts	I-Multi-tissue_structure
.	O

This	O
review	O
focuses	O
on	O
recent	O
approaches	O
in	O
the	O
development	O
of	O
new	O
gene	O
delivery	O
vectors	O
,	O
with	O
great	O
respect	O
to	O
newly	O
discovered	O
AAV	O
serotypes	O
and	O
their	O
modified	O
forms	O
.	O

Moreover	O
,	O
some	O
new	O
cardiovascular	B-Anatomical_system
gene	O
therapy	O
strategies	O
have	O
been	O
highlighted	O
,	O
such	O
as	O
combination	O
of	O
different	O
angiogenic	O
growth	O
factors	O
or	O
simultaneous	O
application	O
of	O
genes	O
and	O
progenitor	B-Cell
cells	I-Cell
in	O
order	O
to	O
obtain	O
stable	O
and	O
functional	O
blood	B-Multi-tissue_structure
vessels	I-Multi-tissue_structure
in	O
ischemic	O
tissue	B-Tissue
.	O

